secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K/A
Filed at:   2022-12-22T23:59:59+00:00
Accession:  0000926617-22-000072
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director James T. LaFrance resigns; Dr. Robert Auerbach joins Audit Committee
-----------------------------------------------------------------------------

- James T. LaFrance resigned from the board of directors effective December 15, 2022.
- Dr. Robert Auerbach appointed to the Audit Committee of the board.
- Amendment corrects a typo: Minh Merchant is General Counsel/Corporate Secretary, not Interim CFO.
- No other changes to the original Dec 21, 2022 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000072/0000926617-22-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661722000072/awh-20221215x8ka.htm
  HTML page:      https://secwatch.observer/filing/0000926617-22-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer